Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations.

The Journal of nutrition·2020
Same author

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.

PloS one·2018
Same author

Relations of mitochondrial genetic variants to measures of vascular function.

Mitochondrion·2017
Same author

Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2017
Same author

Reply.

Journal of hypertension·2016
Same author

Cross-Sectional Associations of Flow Reversal, Vascular Function, and Arterial Stiffness in the Framingham Heart Study.

Arteriosclerosis, thrombosis, and vascular biology·2016
Same journal

Ketohexokinase: A central mediator of fructose-associated pathogenesis and promising therapeutic target.

Pharmacological research·2026
Same journal

GLP-1-based combination strategies for weight loss: Multi-target agents and combination therapies.

Pharmacological research·2026
Same journal

Cajaninstilbene Acid in Macrophage Immunometabolism and Angiogenesis: Mechanisms and Therapeutic Potential.

Pharmacological research·2026
Same journal

From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal Pain.

Pharmacological research·2026
Same journal

Natural product emodin-based nanodrug delivery systems: Advancements and applications.

Pharmacological research·2026
Same journal

Targeting androgen receptor transcriptionally represses VCP and enhances the efficacy of oncolytic-immunotherapy in hepatocellular carcinoma.

Pharmacological research·2026
See all related articles

Related Experiment Videos

Tea and cardiovascular disease.

Apranta Deka1, Joseph A Vita

  • 1Evans Department of Medicine and the Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, United States.

Pharmacological Research
|April 12, 2011
PubMed
Summary
This summary is machine-generated.

Tea consumption shows potential benefits for cardiovascular disease, with evidence suggesting positive effects on risk factors. However, conclusive recommendations for general or patient populations remain uncertain due to mixed results and confounding factors.

Related Experiment Videos

Area of Science:

  • Cardiovascular Disease Research
  • Nutritional Epidemiology
  • Pharmacology

Background:

  • Growing evidence suggests tea consumption may protect against cardiovascular disease (CVD).
  • Existing research presents mixed findings regarding tea's protective effects on CVD.
  • Understanding tea's impact on cardiovascular health requires a comprehensive review of current data.

Purpose of the Study:

  • To review epidemiological data on tea consumption and cardiovascular disease.
  • To examine observational and intervention studies on tea's effects on cardiovascular risk factors.
  • To explore potential biological mechanisms underlying tea's cardiovascular benefits.

Main Methods:

  • Systematic review of epidemiological studies.
  • Analysis of observational and intervention studies on tea and cardiovascular risk factors (blood pressure, lipids, diabetes, obesity).
  • Review of experimental and translational studies on proposed mechanisms of action.

Main Results:

  • Epidemiological data provide mixed evidence for tea's protective effect against CVD, with potential confounding from lifestyle factors.
  • Observational and intervention studies indicate favorable effects of tea on cardiovascular risk factors.
  • Plausible mechanisms, including anti-inflammatory, antioxidant, and endothelial effects, have been identified.

Conclusions:

  • While evidence suggests tea consumption may benefit cardiovascular risk factors through various mechanisms, definitive conclusions are pending.
  • The current body of evidence is insufficient to recommend tea consumption universally for cardiovascular risk reduction.
  • Further research is needed to clarify tea's role in cardiovascular disease prevention strategies.